全文获取类型
收费全文 | 150188篇 |
免费 | 31240篇 |
国内免费 | 2389篇 |
专业分类
耳鼻咽喉 | 5176篇 |
儿科学 | 5346篇 |
妇产科学 | 2466篇 |
基础医学 | 3034篇 |
口腔科学 | 1499篇 |
临床医学 | 26556篇 |
内科学 | 47044篇 |
皮肤病学 | 7433篇 |
神经病学 | 14718篇 |
特种医学 | 6320篇 |
外科学 | 40881篇 |
综合类 | 231篇 |
现状与发展 | 72篇 |
一般理论 | 3篇 |
预防医学 | 6983篇 |
眼科学 | 3390篇 |
药学 | 871篇 |
中国医学 | 6篇 |
肿瘤学 | 11788篇 |
出版年
2024年 | 684篇 |
2023年 | 4781篇 |
2022年 | 1171篇 |
2021年 | 3044篇 |
2020年 | 6001篇 |
2019年 | 2120篇 |
2018年 | 7357篇 |
2017年 | 7314篇 |
2016年 | 8387篇 |
2015年 | 8372篇 |
2014年 | 15458篇 |
2013年 | 15554篇 |
2012年 | 5393篇 |
2011年 | 5384篇 |
2010年 | 10299篇 |
2009年 | 14198篇 |
2008年 | 5721篇 |
2007年 | 3966篇 |
2006年 | 6428篇 |
2005年 | 3722篇 |
2004年 | 2997篇 |
2003年 | 1973篇 |
2002年 | 2077篇 |
2001年 | 3792篇 |
2000年 | 3010篇 |
1999年 | 3208篇 |
1998年 | 3651篇 |
1997年 | 3458篇 |
1996年 | 3363篇 |
1995年 | 3214篇 |
1994年 | 1939篇 |
1993年 | 1569篇 |
1992年 | 1371篇 |
1991年 | 1417篇 |
1990年 | 1066篇 |
1989年 | 1189篇 |
1988年 | 1026篇 |
1987年 | 860篇 |
1986年 | 897篇 |
1985年 | 723篇 |
1984年 | 555篇 |
1983年 | 531篇 |
1982年 | 516篇 |
1981年 | 407篇 |
1980年 | 363篇 |
1979年 | 311篇 |
1978年 | 331篇 |
1977年 | 403篇 |
1975年 | 281篇 |
1972年 | 311篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
11.
12.
Fibromyalgia is a syndrome of widespread pain, nonrestorative sleep, disturbed mood, and fatigue. Optimal treatment involves
a multidisciplinary approach with a team of health care providers using pharmacologic and nonpharmacologic treatment. Because
of the heterogeneity of the illness, management should be individualized for the patient. Pharmacologic treatment should address
issues of pain control, sleep disturbance, fatigue, and any underlying coexisting mood disorder. Nonpharmacologic treatment
should include patient education, a regular exercise and stretching program, and cognitive behavioral therapy. All of these
are essential to improving functional capacity and quality of life. This review provides general guidelines in initiating
a successful pharmacologic treatment program for patients with fibromyalgia. 相似文献
13.
14.
15.
16.
17.
Lucia Nogovà MD Volker Diehl MD Andreas Engert MD 《Current hematologic malignancy reports》2006,1(1):60-65
Lymphocyte-predominant Hodgkin’s lymphoma (LPHL) differs in histologic and clinical presentation from classical Hodgkin’s
lymphoma (cHL). Treatment of LPHL patients using standard Hodgkin’s lymphoma protocols leads to complete remission in more
than 95% of patients. Survival and freedom from treatment failure are substantially worse in advanced-stage patients than
for early-stage patients. Thus, patients in advanced stages and those in early stages with unfavorable risk factors should
be treated similar to those with cHL. In contrast, patients with early-stage LPHL without risk factors might be sufficiently
treated with reduced-intensity programs having less severe adverse effects. As a result, treatment of early LPHL is rather
heterogeneous, including radiotherapy using extended-fleld technique, involved-fleld radiotherapy (IF-RT), combined-modality
treatment, and, more recently, monoclonal antibodies. Watch-and-wait strategy plays an important role in pediatric oncology,
to avoid adverse effects associated with therapy. IF-RT seems to be emerging as a treatment of choice for patients with stage
IA LPHL; most larger study groups, such as the German Hodgkin Study Group and the European Organisation for Research and Treatment
of Cancer, have adopted IF-RT as the treatment of choice for these patients. 相似文献
18.
Rajnish Mago MD John-Paul Gomez MD Namita Gupta MBBS Elisabeth J. S. Kunkel MD 《Current psychiatry reports》2006,8(3):228-233
Anxiety disorders and anxiety symptoms are highly prevalent in the general population and more so in the medically ill. They
have a number of negative consequences for these patients and may worsen the outcome of the medical illness and increase health
care utilization. In the evaluation of these patients, it is of paramount importance to identify the etiology of the anxiety
and, in particular, to differentiate primary from secondary anxiety. Management includes medications (especially benzodiazepines
and selective serotonin reuptake inhibitors) and psychotherapy (particularly cognitive-behavioral therapy). 相似文献
19.
20.
The molecular and clinical impact of hepatocyte growth factor, its receptor, activators, and inhibitors in wound healing 总被引:1,自引:0,他引:1
Kevin Conway MRCS ; Patricia Price PhD ; Keith G. Harding FRCS ; Wen G. Jiang MD 《Wound repair and regeneration》2006,14(1):2-10
Wound healing involves a number of cellular and molecular events, many of which are controlled by soluble growth factors. In the process of healing, hepatocyte growth factor, a cytokine known to act as mitogen, motogen, and morphogen, has been postulated to play multiple roles during several stages of this complex biological process. Produced primarily by stromal fibroblasts, hepatocyte growth factor regulates angiogenesis, vascular permeability, cell migration, matrix deposition and degradation, and other biological processes. The current article discusses recent progress in understanding the multiple roles played by this growth factor in tissue repair. 相似文献